Add like
Add dislike
Add to saved papers

Semimembranosus-tibial collateral ligament bursitis: MR imaging findings.

PURPOSE: The purpose of this paper is to describe the MR imaging characteristics of semimembranosus-tibial collateral ligament (SMTCL) bursitis.

MATERIALS AND METHODS: Fifteen patients (37-68 years old) with medial joint pain and presumed internal derangements of the knee underwent MR imaging. Fluid collections around the SMTCL were found prospectively in five patients. Our retrospective evaluation of recent MR imaging cases that had been previously diagnosed as pes anserinus bursitis revealed 10 additional cases with similar findings.

RESULTS: We believe that SMTCL bursitis clinically explained the patients' medial pain in all cases diagnosed prospectively. We gave the additional cases the same diagnosis presumptively.

CONCLUSIONS: SMTCL bursitis has a characteristic MR imaging appearance of fluid draped over the semimembranosus tendon in the shape of an inverted U. This entity can clinically mimic internal derangement of the knee, typically causing pain more superior and posterior to that of pes anserinus bursitis. MR imaging is useful in diagnosing SMTCL bursitis and avoiding unnecessary knee arthroscopy.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app